Kong L - Search Results

1

Evaluating the association of autonomic drug use to the development and severity of retinopathy of prematurity.

Hussein MA, Coats DK, Khan H, Paysse EA, Steinkuller PG, Kong L, O'Brian SE. Hussein MA, et al. Among authors: kong l. J AAPOS. 2014 Aug;18(4):332-7. doi: 10.1016/j.jaapos.2014.02.012. J AAPOS. 2014. PMID: 25173894

2

An update on progress and the changing epidemiology of causes of childhood blindness worldwide.

Kong L, Fry M, Al-Samarraie M, Gilbert C, Steinkuller PG. Kong L, et al. J AAPOS. 2012 Dec;16(6):501-7. doi: 10.1016/j.jaapos.2012.09.004. J AAPOS. 2012. PMID: 23237744

3

Atropine vs patching for treatment of moderate amblyopia: follow-up at 15 years of age of a randomized clinical trial.

Repka MX, Kraker RT, Holmes JM, Summers AI, Glaser SR, Barnhardt CN, Tien DR; Pediatric Eye Disease Investigator Group. Repka MX, et al. JAMA Ophthalmol. 2014 Jul;132(7):799-805. doi: 10.1001/jamaophthalmol.2014.392. JAMA Ophthalmol. 2014. PMID: 24789375 Free PMC article. Clinical Trial.

4

Pharmacokinetics of bevacizumab and its effects on serum VEGF and IGF-1 in infants with retinopathy of prematurity.

Kong L, Bhatt AR, Demny AB, Coats DK, Li A, Rahman EZ, Smith OE, Steinkuller PG. Kong L, et al. Invest Ophthalmol Vis Sci. 2015 Jan 22;56(2):956-61. doi: 10.1167/iovs.14-15842. Invest Ophthalmol Vis Sci. 2015. PMID: 25613938 Clinical Trial.

5

Evaluation of the Intermittent Exotropia Questionnaire using Rasch analysis.

Leske DA, Holmes JM, Melia BM; Pediatric Eye Disease Investigator Group. Leske DA, et al. JAMA Ophthalmol. 2015 Apr;133(4):461-5. doi: 10.1001/jamaophthalmol.2014.5622. JAMA Ophthalmol. 2015. PMID: 25634146 Free PMC article.

6

Time course and predictors of amblyopia improvement with 2 hours of daily patching.

Wallace DK, Lazar EL, Crouch ER 3rd, Hoover DL, Kraker RT, Tamkins SM; Pediatric Eye Disease Investigator Group. Wallace DK, et al. JAMA Ophthalmol. 2015 May;133(5):606-9. doi: 10.1001/jamaophthalmol.2015.6. JAMA Ophthalmol. 2015. PMID: 25695355 Free PMC article. No abstract available.

7

Evaluation of structural contributors in myopic eyes of preterm and full-term children.

Bhatti S, Paysse EA, Weikert MP, Kong L. Bhatti S, et al. Among authors: kong l. Graefes Arch Clin Exp Ophthalmol. 2016 May;254(5):957-62. doi: 10.1007/s00417-016-3307-0. Epub 2016 Feb 29. Graefes Arch Clin Exp Ophthalmol. 2016. PMID: 26924797

8

Assessment of Plasma Cytokine Profile Changes in Bevacizumab-Treated Retinopathy of Prematurity Infants.

Kong L, Demny AB, Sajjad A, Bhatt AR, Devaraj S. Kong L, et al. Invest Ophthalmol Vis Sci. 2016 Apr;57(4):1649-54. doi: 10.1167/iovs.15-18528. Invest Ophthalmol Vis Sci. 2016. PMID: 27054517

9

Colorado retinopathy of prematurity model: a multi-institutional validation study.

Cao JH, Wagner BD, Cerda A, McCourt EA, Palestine A, Enzenauer RW, Braverman RS, Wong RK, Tsui I, Gore C, Robbins SL, Puente MA Jr, Kauffman L, Kong L, Morrison DG, Lynch AM. Cao JH, et al. Among authors: kong l. J AAPOS. 2016 Jun;20(3):220-5. doi: 10.1016/j.jaapos.2016.01.017. Epub 2016 May 7. J AAPOS. 2016. PMID: 27166790

10

Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing Study.

Wallace DK, Kraker RT, Freedman SF, Crouch ER, Hutchinson AK, Bhatt AR, Rogers DL, Yang MB, Haider KM, VanderVeen DK, Siatkowski RM, Dean TW, Beck RW, Repka MX, Smith LE, Good WV, Hartnett ME, Kong L, Holmes JM; Pediatric Eye Disease Investigator Group (PEDIG). Wallace DK, et al. Among authors: kong l. JAMA Ophthalmol. 2017 Jun 1;135(6):654-656. doi: 10.1001/jamaophthalmol.2017.1055. JAMA Ophthalmol. 2017. PMID: 28448664 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,862 results

Search Page